A detailed history of Rathbones Group PLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Rathbones Group PLC holds 13,714 shares of EXAS stock, worth $767,709. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,714
Previous 13,714 -0.0%
Holding current value
$767,709
Previous $579,000 61.14%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $60,269 - $90,522
914 Added 7.14%
13,714 $935,000
Q3 2017

Oct 24, 2017

BUY
$37.05 - $47.12 $474,239 - $603,136
12,800
12,800 $603,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.91B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.